Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, B eijing, C hina-Reference-Cited by-同舟云学术

Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, B eijing, C hina

Published:2013-09-23 Issue:10 Volume:28 Page:1654-1659
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Yan Jie¹,Xie Wen¹,Ou Wei‐ni¹,Zhao Hong¹,Wang Su‐yun²,Wang Jian‐hui³,Wang Qi¹,Yang Yu‐ying¹,Feng Xin¹,Cheng Jun¹

Affiliation:

1. Center of Liver DiseasesBeijing Ditan Hospital, Capital Medical University Beijing China

2. Community Health Service Center of Tongzhou District Beijing China

3. Community Health Service Center of Dongcheng District Beijing China

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.12290

Reference28 articles.

1. The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

2. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease

3. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China

4. Guidelines for diagnosis and treatment of alcoholic liver diseases;The Chinese National Workshop on Fatty Liver and Alcoholic Liver Disease;Zhonghua Gan Zang Bing Za Zhi,2006

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiological characteristics of alcohol-related liver disease in China: a systematic review and meta-analysis;BMC Public Health;2023-07-01

2. Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis;Hepatology Communications;2023-04-26

3. Increased CHCHD2 expression promotes liver fibrosis in nonalcoholic steatohepatitis via Notch/osteopontin signaling;JCI Insight;2022-12-08

4. Identification of differentially expressed miRNAs and key genes involved in the progression of alcoholic fatty liver disease using rat models;Clinics and Research in Hepatology and Gastroenterology;2022-12

5. A small H2O-soluble ingredient of royal jelly lower cholesterol levels in liver cells by suppressing squalene epoxidase;Heliyon;2022-12